Recovery of the Gut Microbiome following Fecal Microbiota Transplantation

被引:264
作者
Seekatz, Anna M. [1 ]
Aas, Johannes [2 ]
Gessert, Charles E. [3 ]
Rubin, Timothy A. [2 ]
Saman, Daniel M. [3 ]
Bakken, Johan S. [4 ]
Young, Vincent B. [1 ]
机构
[1] Univ Michigan, Dept Microbiol & Immunol, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Essentia Hlth, Dept Gastroenterol, Duluth, MN USA
[3] Essentia Inst Rural Hlth, Duluth, MN USA
[4] St Lukes Hosp, Infect Dis Sect, Duluth, MN USA
关键词
CLOSTRIDIUM-DIFFICILE INFECTION; ULCERATIVE-COLITIS; DISEASE; ACID;
D O I
10.1128/mBio.00893-14
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
Clostridium difficile infection is one of the most common health care-associated infections, and up to 40% of patients suffer from recurrence of disease following standard antibiotic therapy. Recently, fecal microbiota transplantation (FMT) has been successfully used to treat recurrent C. difficile infection. It is hypothesized that FMT aids in recovery of a microbiota capable of colonization resistance to C. difficile. However, it is not fully understood how this occurs. Here we investigated changes in the fecal microbiota structure following FMT in patients with recurrent C. difficile infection, and imputed a hypothetical functional profile based on the 16S rRNA profile using a predictive metagenomic tool. Increased relative abundance of Bacteroidetes and decreased abundance of Proteobacteria were observed following FMT. The fecal microbiota of recipients following transplantation was more diverse and more similar to the donor profile than the microbiota prior to transplantation. Additionally, we observed differences in the imputed metagenomic profile. In particular, amino acid transport systems were overrepresented in samples collected prior to transplantation. These results suggest that functional changes accompany microbial structural changes following this therapy. Further identification of the specific community members and functions that promote colonization resistance may aid in the development of improved treatment methods for C. difficile infection. IMPORTANCE Within the last decade, Clostridium difficile infection has surpassed other bacterial infections to become the leading cause of nosocomial infections. Antibiotic use, which disrupts the gut microbiota and its capability in providing colonization resistance against C. difficile, is a known risk factor in C. difficile infection. In particular, recurrent C. difficile remains difficult to treat with standard antibiotic therapy. Fecal microbiota transplantation (FMT) has provided a successful treatment method for some patients with recurrent C. difficile infection, but its mechanism and long-term effects remain unknown. Our results provide insight into the structural and potential metabolic changes that occur following FMT, which may aid in the development of new treatment methods for C. difficile infection.
引用
收藏
页数:9
相关论文
共 38 条
[1]
Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube [J].
Aas, J ;
Gessert, CE ;
Bakken, JS .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :580-585
[2]
Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome [J].
Abubucker, Sahar ;
Segata, Nicola ;
Goll, Johannes ;
Schubert, Alyxandria M. ;
Izard, Jacques ;
Cantarel, Brandi L. ;
Rodriguez-Mueller, Beltran ;
Zucker, Jeremy ;
Thiagarajan, Mathangi ;
Henrissat, Bernard ;
White, Owen ;
Kelley, Scott T. ;
Methe, Barbara ;
Schloss, Patrick D. ;
Gevers, Dirk ;
Mitreva, Makedonka ;
Huttenhower, Curtis .
PLOS COMPUTATIONAL BIOLOGY, 2012, 8 (06)
[3]
Clostridium difficile infection: epidemiology, risk factors and management [J].
Ananthakrishnan, Ashwin N. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (01) :17-26
[4]
Temporal Bacterial Community Dynamics Vary Among Ulcerative Colitis Patients After Fecal Microbiota Transplantation [J].
Angelberger, Sieglinde ;
Reinisch, Walter ;
Makristathis, Athanasios ;
Lichtenberger, Cornelia ;
Dejaco, Clemens ;
Papay, Pavol ;
Novacek, Gottfried ;
Trauner, Michael ;
Loy, Alexander ;
Erry, David B. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (10) :1620-1630
[5]
Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea [J].
Antharam, Vijay C. ;
Li, Eric C. ;
Ishmael, Arif ;
Sharma, Anuj ;
Mai, Volker ;
Rand, Kenneth H. ;
Wang, Gary P. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (09) :2884-2892
[6]
An overview of fecal microbiota transplantation: techniques, indications, and outcomes [J].
Brandt, Lawrence J. ;
Aroniadis, Olga C. .
GASTROINTESTINAL ENDOSCOPY, 2013, 78 (02) :240-249
[7]
BRAUN J, 2013, MICROBIOME, V1, P17
[8]
Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea [J].
Chang, Ju Young ;
Antonopoulos, Dionysios A. ;
Kalra, Apoorv ;
Tonelli, Adriano ;
Khalife, Walid T. ;
Schmidt, Thomas M. ;
Young, Vincent B. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (03) :435-438
[9]
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].
Cohen, Stuart H. ;
Gerding, Dale N. ;
Johnson, Stuart ;
Kelly, Ciaran P. ;
Loo, Vivian G. ;
McDonald, L. Clifford ;
Pepin, Jacques ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455
[10]
Transient Flare of Ulcerative Colitis After Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection [J].
De Leon, Lauren M. ;
Watson, James B. ;
Kelly, Colleen R. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) :1036-1038